{
    "2019-04-18": [
        [
            {
                "time": "2023-10-05",
                "original_text": "A Diabetes Treatment Revolution Could Bolster These Medtech Firms",
                "features": {
                    "keywords": [
                        "Diabetes",
                        "Treatment",
                        "Revolution",
                        "Bolster",
                        "Medtech"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "An Abbott Labs Analyst's 5 Reasons To Own The Stock: 'Near-Perfect For This Environment'",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Labs",
                        "Analyst",
                        "Reasons",
                        "Own",
                        "Stock",
                        "Near-Perfect",
                        "Environment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}